We next investigated whether restoration of cell-surface DR4 levels by TACE inhibition is able to enhance the cytotoxic effects of TRAIL or an agonistic antibody against DR4 on MM cells. This evidence concerns the gene ADAM17 and Miyoshi myopathy.